NEURO62

Presentation information

Symposium

[S-13] Symposium 13 Will new migraine medications save migraine patients?

Thu. May 20, 2021 8:00 AM - 9:30 AM Room 04 (ICC Kyoto 2F Room A)

Chair:Igarashi Hisaka(Headache Care Unit, Department of Internal Medicine, Fujitsu Clinic),Takahashi Makio(Department of Neurology, Osaka Red Cross Hospital)

後援:日本頭痛学会

[S-13-1] The disability of migraine in Japan

Toshihiko Shimizu (Department of Neurology, Keio University, Japan)

photo
Toshihiko Shimizu, M.D., Ph.D.

EDUCATIONAL AND DEGREES
M.D.: Keio University, School of Medicine 1990
DMSc: Keio University, Graduate School of Medicine 1995

TRAINING HISTORY
Resident in Internal Medicine and Neurology, Keio University 1990-1994
Instructor of Neurology, Keio University 1994-1999, 2002-2005
Instructor of Neurology, National Hospital Organization of Tokyo Medical center 2005-2006
Assistant Professor of Neurology, Keio University, 2006-2018
Occupational health physician at EBARA Corporation, 2018-
Part-time Lecturer, Keio University, 2018-

PROFESSIONAL CREDENTIALS
Licensure by the Japanese National Board Examination for Medical Practice 1990
Certification by the Japanese Board of Neurology 1994
Certification by the Japanese Board of Stroke, 2003
Certification by the Japanese Board of Internal medicine, 2004
Certification by the Japanese Board of Headache, 2005

Abstract password authentication.
Password is written on a pocket program and name badge.

Password